A methylation-phosphorylation switch controls EZH2 stability and hematopoiesis
eLife · 2024
DOI: 10.7554/elife.86168 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Pengfei Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Nevada, Las Vegas, Las Vegas, United States. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Histones. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
The Polycomb Repressive Complex 2 (PRC2) methylates H3K27 to regulate development and cell fate by transcriptional silencing. Alteration of PRC2 is associated with various cancers. Here, we show that mouse Kdm1a deletion causes a dramatic reduction of PRC2 proteins, whereas mouse null mutation of L3mbtl3 or Dcaf5 results in PRC2 accumulation and increased H3K27 trimethylation. The catalytic subunit of PRC2, EZH2, is methylated at lysine 20 (K20), promoting EZH2 proteolysis by L3MBTL3 and the CLR4 DCAF5 ubiquitin ligase. KDM1A (LSD1) demethylates the methylated K20 to stabilize EZH2. K20 methylation is inhibited by AKT-mediated phosphorylation of serine 21 in EZH2. Mouse Ezh2 K20R/K20R mutants develop hepatosplenomegaly associated with high GFI1B expression, and Ezh2 K20R/K20R mutant bone marrows expand hematopoietic stem cells and downstream hematopoietic populations. Our studies reveal that EZH2 is regulated by methylation-dependent proteolysis, which is negatively controlled by AKT-mediated S21 phosphorylation to establish a methylation-phosphorylation switch to regulate the PRC2 activity and hematopoiesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, University of Nevada, Las Vegas, Las Vegas, United States.
ORCID-Profile: Pengfei Guo, Hui Zhang
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Guo, P., Lim, R. C., Rajawasam, K., Trinh, T., Sun, H., & Zhang, H. (2024). A methylation-phosphorylation switch controls EZH2 stability and hematopoiesis. eLife. https://doi.org/10.7554/elife.86168
Vancouver
Guo P, Lim RC, Rajawasam K, Trinh T, Sun H, Zhang H. A methylation-phosphorylation switch controls EZH2 stability and hematopoiesis. eLife. 2024. doi:10.7554/elife.86168
BibTeX
@article{Guo2024,
author = {Guo, Pengfei and Lim, Rebecca C and Rajawasam, Keshari and Trinh, Tiffany and Sun, Hong and Zhang, Hui},
title = {A methylation-phosphorylation switch controls EZH2 stability and hematopoiesis},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.86168}
}
EUVIMED